Found: 17
Select item for more details and to access through your institution.
A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37347-6
- By:
- Publication type:
- Article
The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 9, p. 1, doi. 10.1371/journal.ppat.1012525
- By:
- Publication type:
- Article
Germinal center cytokines driven epigenetic control of Epstein-Barr virus latency gene expression.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1011939
- By:
- Publication type:
- Article
SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21903-z
- By:
- Publication type:
- Article
Capravirine, a Nonnucleoside Reverse-Transcriptase Inhibitor in Patients Infected with HIV-1: A Phase 1 Study.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 11, p. 1957, doi. 10.1086/425581
- By:
- Publication type:
- Article
The nuclear lamina binds the EBV genome during latency and regulates viral gene expression.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 4, p. 1, doi. 10.1371/journal.ppat.1010400
- By:
- Publication type:
- Article
Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 2, p. 1, doi. 10.1371/journal.ppat.1010254
- By:
- Publication type:
- Article
Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.651013
- By:
- Publication type:
- Article
CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 2, p. 55, doi. 10.3390/v10020055
- By:
- Publication type:
- Article
NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1.
- Published in:
- Viruses (1999-4915), 2013, v. 5, n. 6, p. 1587, doi. 10.3390/v5061587
- By:
- Publication type:
- Article
TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 5, p. 1, doi. 10.1371/journal.ppat.1004890
- By:
- Publication type:
- Article
EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 5, p. 1076, doi. 10.1007/s10120-021-01193-6
- By:
- Publication type:
- Article
Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 9, p. 1, doi. 10.1371/journal.pgen.1004642
- By:
- Publication type:
- Article
The nucleic acid binding protein SFPQ represses EBV lytic reactivation by promoting histone H1 expression.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48333-x
- By:
- Publication type:
- Article
Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 9, p. 1, doi. 10.1371/journal.ppat.1008030
- By:
- Publication type:
- Article
Persistent and Relapsing Babesiosis in Immunocompromised Patients.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 3, p. 370, doi. 10.1086/525852
- By:
- Publication type:
- Article
Correction: Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice